|
SLC25A46 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.14539513826639E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.47699646852107E-11 |
| Normal-vs-Stage2 |
6.423500E-04 |
| Normal-vs-Stage3 |
2.342000E-03 |
| Normal-vs-Stage4 |
1.7946199999952E-05 |
| Stage1-vs-Stage2 |
4.374800E-01 |
| Stage1-vs-Stage3 |
1.552800E-01 |
| Stage1-vs-Stage4 |
8.361600E-01 |
| Stage2-vs-Stage3 |
6.989400E-01 |
| Stage2-vs-Stage4 |
4.627000E-01 |
| Stage3-vs-Stage4 |
3.325600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.25539578732514E-11 |
| Normal-vs-AfricanAmerican |
7.18460000381782E-08 |
| Normal-vs-Asian |
4.500600E-01 |
| Caucasian-vs-AfricanAmerican |
5.300200E-01 |
| Caucasian-vs-Asian |
5.569800E-01 |
| AfricanAmerican-vs-Asian |
6.351600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.06246131284615E-12 |
| Normal-vs-Female |
3.62740000000583E-05 |
| Male-vs-Female |
6.124500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.42029999997229E-06 |
| Normal-vs-Extreme_Weight |
2.01505478969466E-12 |
| Normal-vs-Obese |
5.23569999577589E-08 |
| Normal-vs-Extreme_Obese |
9.283700E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.493600E-01 |
| Normal_Weight-vs-Obese |
8.220000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.276200E-01 |
| Extreme_Weight-vs-Obese |
7.587700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.136400E-01 |
| Obese-vs-Extreme_Obese |
9.708000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.50210000005035E-06 |
| Normal-vs-Age(41-60Yrs) |
2.39359999598676E-08 |
| Normal-vs-Age(61-80Yrs) |
1.18161036510855E-12 |
| Normal-vs-Age(81-100Yrs) |
2.0142000001222E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.512800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.479600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.938800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.050300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.396800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.184200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.257210E-03 |
| Normal-VS-KIRP CIMP |
1.80629999999571E-05 |
| Normal-VS-Unclassified PRCC |
5.161200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.3982000000018E-05 |
| Type1 PRCC-VS-KIRP CIMP |
4.570000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.624800E-03 |
| Type2 PRCC-VS-KIRP CIMP |
6.097700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.317600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.356800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.79659999999249E-05 |
| Normal-vs-N1 |
2.44640000002239E-06 |
| Normal-vs-N2 |
1.736250E-03 |
| N0-vs-N1 |
7.809400E-01 |
| N0-vs-N2 |
7.642600E-01 |
| N1-vs-N2 |
5.267800E-01 |
|
|
